mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0075 |
0.8 |
mRNA |
procarbazine |
CTRPv2 |
pan-cancer |
AAC |
-0.008 |
0.8 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.0066 |
0.8 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.0065 |
0.8 |
mRNA |
carboplatin:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0074 |
0.8 |
mRNA |
BRD-K16130065 |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
0.007 |
0.8 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.8 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.0068 |
0.8 |